CVRx to Present at the Jefferies Global Healthcare Conference in London

Rhea-AI Summary

CVRx (NASDAQ: CVRX) announced that management will present at the Jefferies Global Healthcare Conference in London on Tuesday, Nov 18, 2025.

The presentation is scheduled for 8:00 a.m. GMT / 4:00 a.m. ET and will be available live via audio webcast on the company investor relations site at ir.cvrx.com.

MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the Jefferies Global Healthcare Conference in London on Tuesday, Nov. 18, 2025. The Company is scheduled to present at 8:00 a.m. (GMT) / 4:00 a.m. (ET) the same day via webcast.

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com.

About CVRx, Inc.

CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has been certified as compliant with the EU Medical Device Regulation (MDR) and holds CE Mark approval for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit www.cvrx.com.

Investor Contact:
Mark Klausner or Mike Vallie
ICR Healthcare
443-213-0501
ir@cvrx.com

Media Contact:
Emily Meyers
CVRx, Inc.
763-416-2853
emeyers@cvrx.com

FAQ

When will CVRx (CVRX) present at the Jefferies Global Healthcare Conference in London?

CVRx will present on Tuesday, Nov 18, 2025.

What time is the CVRx (CVRX) presentation on Nov 18, 2025?

The presentation is scheduled for 8:00 a.m. GMT / 4:00 a.m. ET on Nov 18, 2025.

How can investors watch CVRx (CVRX) present at Jefferies on Nov 18, 2025?

A live audio webcast will be available on CVRx's investor relations site at ir.cvrx.com.

Will CVRx (CVRX) provide a replay of the Jefferies presentation?

The company indicated a live audio webcast will be available; check ir.cvrx.com for replay availability after the event.

Who from CVRx (CVRX) is scheduled to present at the Jefferies Global Healthcare Conference?

The announcement states the company's management team will present; specific presenter names were not provided.

Does the CVRx (CVRX) announcement include financial or clinical data for the Jefferies presentation?

No; the announcement only confirms the presentation date, time, and webcast access without financial or clinical details.